Cannabis Webinar—Scientific Standards in Cannabis, Gaps, and How Industry Aligns

Cannabis Webinar

Scientific Standards in Cannabis, Gaps, and How Industry Aligns

On Thursday, January 20, 2022, Perkins Coie hosted a panel discussion addressing the scientific standards in cannabis. The panel was moderated by Andrew Kline, senior counsel at Perkins Coie and former public policy director for the National Cannabis Industry Association. Our panelists included Dr. Stephen Dahmer, chief medical officer of Goodness Growth Holdings/Vireo Health, Alena Rodriguez, managing director at Rm3 Labs, Kathleen May, chair of ASTM International's D37 Committee on Cannabis, and Nandakumara (Nandu) Sarma, director of dietary supplements and herbal medicines at US Pharmacopeia (USP).

If you are interested in receiving a copy of the recording, please contact Rebecca Grube.

Speakers included:

• Dr. Stephen Dahmer
  Chief Medical Officer, Goodness Growth Holdings / Vireo Health
• Alena Rodriguez
  Managing Director, Rm3 Labs
• Kathleen May
  Chair of ASTM International's D37 Committee on Cannabis
• Nandakumara (Nandu) Sarma
  Director of Dietary Supplements and Herbal Medicines, US Pharmacopeia (USP)

Moderator:

• Andrew Kline
  Senior Counsel, Perkins Coie